Endovascular Engineering, Inc.
PrivateLast Round
Series C
Apr 7, 2026
Est. Valuation
$70M
Total Funding Raised
$137.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Endovascular Engineering, Inc. is a medical technology company that develops and deploys next-generation clot removal technologies targeting venous thromboembolism.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endovascular Engineering, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Endovascular Engineering, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 7, 2026 | ||||
| Series B | Feb 18, 2025 | ||||
| Series A Extension | Apr 5, 2022 | ||||
| Grant | Sep 20, 2021 |
Key People
Founding team and executive leadership
Endovascular Engineering, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| 415 Capital | Series C, Series B |
| Gilde Healthcare | Series C |
| Santé Ventures | Series C, Series B, Series A Extension |
| Norwest Venture Partners | Series C |
| Panakès Partners | Series C, Series B |
| M&L Healthcare | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
$80M Series C round completed.
- Sep 7, 2025
Grew 23% QoQ from 30 to 37 employees.
Endovascular Engineering, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endovascular Engineering, Inc.'s valuation, stock price, and market status.